Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus. - Wikidata - awgldk - TriplyDB

Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus.

Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus.

http://www.wikidata.org/entity/Q37076080

about

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk Transcriptome profiling reveals novel BMI- and sex-specific gene expression signatures for human cardiac hypertrophy.Integrating Biomarkers and Imaging for Cardiovascular Disease Risk Assessment in Diabetes.Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin.Diabetic Cardiomyopathy: Current Approach and Potential Diagnostic and Therapeutic Targets.Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional Study KDM3A inhibition attenuates high concentration insulin‑induced vascular smooth muscle cell injury by suppressing MAPK/NF‑κB pathways.Biomarkers for cardiovascular risk in patients with diabetes.Biomarkers of cardiovascular disease: contributions to risk prediction in individuals with diabetes.Bone markers and cardiovascular risk in type 2 diabetes patients.The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications.Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice

P2860

Q33715302-2EA293FD-ADE4-4508-89CC-9B4F87ECE8D9 Q38788545-FE116725-AA24-4AF9-9B55-3773D9392E93 Q38950340-742986A4-F4C5-42EE-983D-78CE3C9CB42B Q39176937-3A00DB8C-0A4C-48F9-9A98-27B875C57EE6 Q39249730-AE4C78F3-2A82-4CAC-818F-A75D78DC1473 Q40094602-927691C7-1CBD-4F29-AFEF-F6683BCF1203 Q41096059-E3A4C051-B6B6-4DDB-A57F-AE71F0D61891 Q47246628-89615690-1E88-4413-B7F4-DC46CE065CE6 Q48359696-5D7B0969-6CA2-4ACE-9B67-17BFC3FEF662 Q49691813-5066FC46-B179-470C-A746-1B67BD27F772 Q53738261-C11C73ED-DB6D-4C63-B438-929A60C8F9D7 Q55315552-D40CF3F1-D739-4B6D-A652-62FD210B4027 Q58762112-79F73D51-8BA2-42B3-AFEA-3057CF20033F

P2860

Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus.

http://www.wikidata.org/entity/Q37076080

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Novel Biomarkers to Improve th ...... k in Type 2 Diabetes Mellitus.

@en

Novel Biomarkers to Improve th ...... k in Type 2 Diabetes Mellitus.

@nl

type

label

Novel Biomarkers to Improve th ...... k in Type 2 Diabetes Mellitus.

@en

Novel Biomarkers to Improve th ...... k in Type 2 Diabetes Mellitus.

@nl

prefLabel

Novel Biomarkers to Improve th ...... k in Type 2 Diabetes Mellitus.

@en

Novel Biomarkers to Improve th ...... k in Type 2 Diabetes Mellitus.

@nl

P1433

Q37076080-07362286-B60F-449F-95ED-9D1AE926AFA0

P1476

Q37076080-261E5973-A4CC-44BB-87BB-3156BEDE6F0E

P2093

Q37076080-003FF978-7C63-4EC3-BDFF-2962F6A21D6B

Q37076080-047D2508-05F1-48E7-8C2E-0200682D7BF5

Q37076080-1D9C8EC1-D0D1-4595-BF66-4C24F5C98512

Q37076080-2AFCC8A5-90B7-4740-8E0D-83364C19621F

Q37076080-35F96779-B7E5-45B7-A943-186924EA71D7

Q37076080-41C4D905-B5A1-4606-ACA4-E387E0E9C298

Q37076080-46E24232-3165-4A6A-8165-81F7AF80DDA6

Q37076080-669840C1-2955-43C3-93CF-CFC634729070

Q37076080-7B1EF66E-465C-4720-B98A-9A0E09019A9C

Q37076080-7EE12C75-D5B0-440E-AE47-6F36B1060B18

P2860

Q37076080-05A351DE-7AEA-42DC-A0C6-005C115BE65E

Q37076080-0D2605F6-4313-4182-91CD-86D040FA61F5

Q37076080-0DD49E6D-3E92-4B97-AEE5-8C403A18AA30

Q37076080-13C74149-40A4-42DE-8DA6-8208365C22D9

Q37076080-1C9197DE-4ADB-4B45-B560-E9F6A1DEEC55

Q37076080-2DA95C3E-FB26-4828-938E-5028EE6BE967

Q37076080-3C9AFE6E-5EEC-4C19-A201-300EEC1560D8

Q37076080-3CD2C925-5286-481F-A6C7-30BB47612A6A

Q37076080-411CD603-294A-42BB-93FD-98DCCD101209

Q37076080-4C881A82-9973-4CF1-9ECD-0663B3FBD328

P31

Q37076080-C917BB39-342B-4FE2-AEDA-7BF932B64A0D

P356

Q37076080-5874770B-41F2-44B6-A274-B6DEAF674420

P433

Q37076080-C68BCD20-CC57-444B-908A-A54E81B1FAB1

P478

Q37076080-459419A7-9515-4E2E-887E-B0762EDB0C48

P50

Q37076080-A4EDA83D-DB83-4931-AA0F-0831DDA21DFF

Q37076080-BE674489-EE71-4726-8E29-A5E47E381CD0

P577

Q37076080-6ED5D6C7-DCFE-4DC2-A9DC-7482BF8EF1C3

P698

Q37076080-2C9A0050-7623-4B97-B4B0-EA1CAB0057A3

P921

Q37076080-04CF6CCE-FEBC-4BC5-9709-466FC9E15DFB

Q37076080-051517FE-D66E-4C77-A689-5657821A0129

Q37076080-CC964B4C-3C45-45DB-B3C0-A5021892A706

P932

Q37076080-148F8CDF-2855-4AEE-B8F1-673C6BF9076C

P356

JAHA.115.003048

P1433

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

P1476

Novel Biomarkers to Improve th ...... sk in Type 2 Diabetes Mellitus

@en

P2093

Casper G Schalkwijk

http://www.w3.org/2001/XMLSchema#string

Jan F C Glatz

http://www.w3.org/2001/XMLSchema#string

Joep van der Leeuw

http://www.w3.org/2001/XMLSchema#string

Jolanda M A Boer

http://www.w3.org/2001/XMLSchema#string

Joline W J Beulens

http://www.w3.org/2001/XMLSchema#string

Linda M Peelen

http://www.w3.org/2001/XMLSchema#string

Marten H Hofker

http://www.w3.org/2001/XMLSchema#string

Susan van Dieren

http://www.w3.org/2001/XMLSchema#string

W M Monique Verschuren

http://www.w3.org/2001/XMLSchema#string

Yolanda van der Graaf

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Analysis of case-cohort data: a comparison of different methods.

Validity of coronary heart diseases and heart failure based on hospital discharge and mortality data in the Netherlands using the cardiovascular registry Maastricht cohort study.

Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts.

Comparison of imputation methods for handling missing covariate data when fitting a Cox proportional hazards model: a resampling study.

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collab

P31

scholarly article

P356

10.1161/JAHA.115.003048

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Yvonne T van der Schouw

Frank L Visseren

P577

2016-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27247335

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

type-2 diabetes

P932

4937255

http://www.w3.org/2001/XMLSchema#string